{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:35:38Z","timestamp":1791232538248,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.intimp.2010.07.002","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T09:33:52Z","timestamp":1279272832000},"page":"1220-1228","source":"Crossref","is-referenced-by-count":85,"title":["The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages"],"prefix":"10.1016","volume":"10","author":[{"given":"Justin P.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leisha A.","family":"Emens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2010.07.002_bb0005","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2249.2008.03741.x","article-title":"Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage\/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism","volume":"154","author":"Chandra","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0015","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1111\/j.1742-4658.2009.07068.x","article-title":"Modelling and simulating interleukin-10 production and regulation by macrophages after stimulation with an immunomodulator of parasitic nematodes","volume":"276","author":"Figueiredo","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.intimp.2010.07.002_bb0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.175.1.469","article-title":"ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus","volume":"175","author":"Lucas","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0025","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.intimp.2010.07.002_bb0030","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2174\/1381612023393026","article-title":"BAY 43-9006: preclinical data","volume":"8","author":"Wilhelm","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.intimp.2010.07.002_bb0035","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2010.07.002_bb0040","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1182\/blood-2007-02-075945","article-title":"Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses","volume":"111","author":"Hipp","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2010.07.002_bb0045","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/leu.2008.58","article-title":"Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation","volume":"22","author":"Zhao","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2010.07.002_bb0050","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.4049\/jimmunol.0902404","article-title":"The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitro","volume":"183","author":"Krusch","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0055","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1158\/1078-0432.CCR-07-0374","article-title":"A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism","volume":"13","author":"Manning","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.intimp.2010.07.002_bb0060","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.4049\/jimmunol.0802703","article-title":"The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages","volume":"182","author":"Edwards","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1401s83","article-title":"The isolation and characterization of murine macrophages","author":"Zhang","year":"2008","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0070","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.181.2.775","article-title":"Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production","volume":"181","author":"van der Pouw Kraan","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2010.07.002_bb0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/107999000312423","article-title":"Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: the role of p38 mitogen-activated protein kinase","volume":"20","author":"Williams","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.intimp.2010.07.002_bb0080","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00262-008-0494-5","article-title":"Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression","volume":"57","author":"Su","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.intimp.2010.07.002_bb0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1006\/bbrc.2000.2341","article-title":"Effects of CTx and 8-bromo-cAMP on LPS-induced gene expression of cytokines in murine peritoneal macrophages","volume":"269","author":"Feng","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2010.07.002_bb0090","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.4049\/jimmunol.176.12.7361","article-title":"The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages","volume":"176","author":"Bryn","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0095","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.189.3.541","article-title":"Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression","volume":"189","author":"Braun","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2010.07.002_bb0100","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.4049\/jimmunol.165.3.1612","article-title":"Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression","volume":"165","author":"Benkhart","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0105","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0110","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1158\/1535-7163.MCT-08-0138","article-title":"Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas","volume":"7","author":"Yang","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.intimp.2010.07.002_bb0115","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/hep.23214","article-title":"Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2","volume":"50","author":"Blechacz","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2010.07.002_bb0120","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.2741\/3122","article-title":"MSK activation and physiological roles","volume":"13","author":"Arthur","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.intimp.2010.07.002_bb0125","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/ni.1644","article-title":"The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling","volume":"9","author":"Ananieva","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0130","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1093\/emboj\/18.17.4779","article-title":"The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3\/HMG-14 kinase","volume":"18","author":"Thomson","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.intimp.2010.07.002_bb0135","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jhep.2009.10.011","article-title":"Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation","volume":"52","author":"Chen","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0145","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1158\/1535-7163.MCT-06-0235","article-title":"Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways","volume":"5","author":"Yu","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.intimp.2010.07.002_bb0150","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1016\/S0021-9258(18)60727-6","article-title":"Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression","volume":"263","author":"Kunkel","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2010.07.002_bb0155","doi-asserted-by":"crossref","first-page":"9692","DOI":"10.1074\/jbc.M709663200","article-title":"Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation","volume":"283","author":"Minami","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2010.07.002_bb0160","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1128\/MCB.24.21.9658-9667.2004","article-title":"Lipopolysaccharide activation of the TPL-2\/MEK\/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105","volume":"24","author":"Beinke","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0165","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/ni.1640","article-title":"The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression","volume":"9","author":"Kim","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0170","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.imbio.2009.06.014","article-title":"Cellular and molecular pathways linking inflammation and cancer","volume":"214","author":"Porta","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2010.07.002_bb0175","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1567-5769(02)00064-4","article-title":"Tumor-associated macrophages: a molecular perspective","volume":"2","author":"Sica","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1158\/0008-5472.CAN-09-3170","article-title":"Central role of IFNgamma-indoleamine 2, 3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity","volume":"70","author":"Gu","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2010.07.002_bb0185","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.4049\/jimmunol.177.10.6962","article-title":"Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector\/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors","volume":"177","author":"Kilinc","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2010.07.002_bb0190","doi-asserted-by":"crossref","first-page":"8700","DOI":"10.1158\/0008-5472.CAN-09-1145","article-title":"Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance","volume":"69","author":"Cao","year":"2009","journal-title":"Cancer Res"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691000216X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691000216X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T15:11:01Z","timestamp":1635693061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691000216X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S156757691000216X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2010.07.002","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}